Dynamic trajectories of possible sarcopenia under the AWGS 2025 criteria and long-term prognosis: A national landmark cohort study.
Key claim: In Chinese adults aged ≥60 free of baseline ADL disability, persistent possible sarcopenia by AWGS 2025 low-handgrip criteria was independently associated with higher all-cause mortality and composite adverse outcomes, whereas persistently normal handgrip predicted the most favorable prognosis.
Abstract
BACKGROUND: Possible sarcopenia is defined by low handgrip strength in the Asian Working Group for Sarcopenia (AWGS) 2025 consensus. Whether functional recovery under these criteria improves long-term prognosis remains unclear. METHODS: The study included 2761 community-dwelling participants aged ≥60 years from the China Health and Retirement Longitudinal Study (CHARLS, 2011-2018) who were free of baseline activities of daily living (ADL) disability. Participants were categorized into four trajectory subgroups based on their possible sarcopenia status in 2011 and 2013: Persistently Normal (72.0%), Reversed Possible Sarcopenia (10.8%), Progressive Possible Sarcopenia (10.8%), and Persistent Possible Sarcopenia (6.5%). Survey-weighted Cox and Fine-Gray competing risk models estimated hazard ratios (HRs) for all-cause mortality and severe ADL disability prevalent at the 2018 follow-up. RESULTS: During a median follow-up of 5.0 years, 258 all-cause deaths and 109 cases of prevalent severe ADL disability were documented. Persistent Possible Sarcopenia was independently associated with higher risks of all-cause mortality (HR 1.75, 95% CI 1.16-2.62) and the composite adverse outcome (HR 1.76, 95% CI 1.22-2.53), with significant ordinal trends. For the Reversed trajectory, severe ADL disability risk did not differ significantly from reference (subdistribution hazard ratio (sHR) 1.40, 95% CI 0.79-2.46). CONCLUSIONS: Persistently Normal handgrip strength predicts the most favorable prognosis, whereas Persistent Possible Sarcopenia carries higher risks of mortality and adverse outcomes. Whether sarcopenia reversal attenuates these risks awaits further study.
Why this matters
Grip strength’s prognostic value is well established, but the AWGS 2025 criteria changed the handgrip thresholds used to flag ‘possible sarcopenia’ in Asian populations, leaving open whether the new cutoffs still stratify long-term outcomes. This cohort shows that two-year trajectories under the updated criteria — not just a single reading — map onto mortality and severe disability, reinforcing grip strength as a repeat-measurement functional biomarker rather than a one-shot screen.